Cross-sectional comparison of synovial fluid biochemical markers in equine osteoarthritis and the correlation of these markers with articular cartilage damage

Osteoarthritis and Cartilage

Volumn 9, Issue 1, 2001, Pages 49-55

  Fuller, C J ^a   Barr, A R ^a   Sharif, M ^a   Dieppe, P A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Biochemical markers; Cartilage; Equine; Osteoarthritis

Indexed keywords

BIOCHEMICAL MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHROSCOPY; ARTICLE; ARTICULAR CARTILAGE; BONE TURNOVER; CARTILAGE; CONTROLLED STUDY; DIAGNOSTIC TEST; HORSE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; SCORING SYSTEM; SYNOVIAL FLUID; VALIDATION PROCESS;

EID: 0035128614     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1053/joca.2000.0349     Document Type: Article

References (31)

1. Correlation between synovial fluid markers of cartilage and bone turnover and scintigraphic scan abnormalities in osteoarthritis of the knee
2. Serum hyaluronic-acid level as a predictor of disease progression in osteoarthritis of the knee
3. Bone-specific alkaline-phosphatase as a marker of bone turnover in osteoarthritis and rheumatoid-arthritis
4. The relevance of chondroitin and keratan sulfate markers in normal and arthritic synovial-fluid
5. Relationship between arthroscopic evidence of cartilage damage and radiographic evidence of joint space narrowing in early osteoarthritis of the knee
6. Do subchondral bone changes exacerbate or precede articular cartilage destruction in osteoarthritis of the elderly?
7. 2 bone alkaline-phosphatase assays compared with osteocalcin as a marker of bone-formation in healthy elderly women
8. Efficacy of wheat-germ lectin-precipitated alkaline-phosphatase in serum as an estimator of bone mineralization rate - Comparison to serum total alkaline-phosphatase and serum bone gla-protein
9. Osteoarthritis of the canine stifle joint
10. Arthroscopic surgery for the treatment of osteochondral chip fractures in the equine carpus
11. Intra-articular hyaluronic acid in osteoarthritis of the knee: An investigation into mechanisms of action
12. Improved quantification and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue
13. Enzyme-linked immunosorbent assay for hyaluronate using cartilage proteoglycan and an antibody to keratan sulphate
14. Hyaluronate and large molecular-weight proteoglycans in synovial-fluid from horses with various arthritides
15. Concentrations of keratan sulfate in plasmeda and synovial fluid from clinically normal horses and horses with joint disease
16. Changes in glycosaminoglycan epitope levels in knee joint fluid following injury
17. Cartilage metabolism in the injured and uninjured knee of the same patient
18. Role of subchondral bone in the initiation and progression of cartilage damage
19. Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone-scintigraphy
20. Osteoarthritis in cynomolgus macaques - A primate model of naturally-occurring disease
21. Arthroscopic evaluation of chondropathy in osteoarthritis of the knee
22. Biochemical markers in synovial-fluid identify early osteoarthritis of the glenohumeral joint
23. Correlation between radiographic and arthroscopic findings in the equine carpus
24. Comparison of radiographic subchondral bone changes with arthroscopic findings in the equine femoropatellar and femorotibial joints - A retrospective study of 72 joints (50 horses)
25. Longitudinal and cross-sectional variability in markers of joint metabolism in patients with knee pain and articular cartilage abnormalities
26. Variation of an epitope of keratan sulphate and total glycosaminoglycans in normal equine joints
27. Quantitative-determination of equine alkaline-phosphatase isoenzymes in foal and adult serum
28. Measurement of bone specific alkaline-phosphatase in the horse - A comparison of 2 techniques
29. Monoclonal-antibody assay for measuring bone-specific alkaline-phosphatase activity in serum
30. Guidelines for testing slow acting drugs in osteoarthritis